Recent developments in the management of detrusor overactivity

Area of Science:

• Urology
• Pharmacology
• Neuroscience

Background:

• Detrusor overactivity significantly impacts quality of life.
• Current treatments, primarily muscarinic receptor antagonists, have limited efficacy and troublesome side effects, leading to poor patient compliance.
• Alternative therapeutic targets are needed for managing detrusor overactivity.

Purpose of the Study:

• To discuss the pharmacological basis of current therapeutic alternatives for detrusor overactivity.
• To explore potential future drug developments targeting alternative pathways.
• To review recent findings on bladder function and neurotransmission.

Main Methods:

• Literature review of current and emerging pharmacological treatments for detrusor overactivity.
• Analysis of the role of the urothelium, ATP, and purinergic receptors in bladder function.
• Examination of central nervous system control of the micturition reflex.

Main Results:

• The urothelium plays a critical role in bladder function, releasing ATP that activates P2X receptors on neurons.
• Non-cholinergic activation via purinergic receptors may occur in abnormal bladders, distinct from muscarinic receptor stimulation in normal bladders.
• Central nervous mechanisms controlling the micturition reflex are gaining attention.

Conclusions:

• Existing treatments for overactive bladder have significant non-compliance rates due to side effects.
• Emerging research highlights the importance of purinergic signaling and central nervous system control in voiding.
• Future research focusing on these alternative pathways holds promise for developing more effective and better-tolerated treatments for detrusor overactivity.